247 related articles for article (PubMed ID: 25701724)
1. The effects of A-803467 on cardiac Nav1.5 channels.
Han Z; Jiang Y; Xiao F; Cao K; Wang DW
Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Gating Properties and Use-Dependent Block of Nav1.5 and Nav1.7 Channels by Anti-Arrhythmics Mexiletine and Lidocaine.
Wang Y; Mi J; Lu K; Lu Y; Wang K
PLoS One; 2015; 10(6):e0128653. PubMed ID: 26068619
[TBL] [Abstract][Full Text] [Related]
4. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.
Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
[TBL] [Abstract][Full Text] [Related]
6. Benzonatate inhibition of voltage-gated sodium currents.
Evans MS; Maglinger GB; Fletcher AM; Johnson SR
Neuropharmacology; 2016 Feb; 101():179-87. PubMed ID: 26386152
[TBL] [Abstract][Full Text] [Related]
7. Human stem cell-derived cardiomyocytes detect drug-mediated changes in action potentials and ion currents.
Gibson JK; Yue Y; Bronson J; Palmer C; Numann R
J Pharmacol Toxicol Methods; 2014; 70(3):255-67. PubMed ID: 25219538
[TBL] [Abstract][Full Text] [Related]
8. Modulation of peripheral Na(+) channels and neuronal firing by n-butyl-p-aminobenzoate.
Thériault O; Poulin H; Sculptoreanu A; de Groat WC; O'Leary ME; Chahine M
Eur J Pharmacol; 2014 Mar; 727():158-66. PubMed ID: 24486399
[TBL] [Abstract][Full Text] [Related]
9. Action potential changes associated with a slowed inactivation of cardiac voltage-gated sodium channels by KB130015.
Macianskiene R; Bito V; Raeymaekers L; Brandts B; Sipido KR; Mubagwa K
Br J Pharmacol; 2003 Aug; 139(8):1469-79. PubMed ID: 12922934
[TBL] [Abstract][Full Text] [Related]
10. Potent Inactivation-Dependent Inhibition of Adult and Neonatal NaV1.5 Channels by Lidocaine and Levobupivacaine.
Elajnaf T; Baptista-Hon DT; Hales TG
Anesth Analg; 2018 Sep; 127(3):650-660. PubMed ID: 29958221
[TBL] [Abstract][Full Text] [Related]
11. SCN5A variant that blocks fibroblast growth factor homologous factor regulation causes human arrhythmia.
Musa H; Kline CF; Sturm AC; Murphy N; Adelman S; Wang C; Yan H; Johnson BL; Csepe TA; Kilic A; Higgins RS; Janssen PM; Fedorov VV; Weiss R; Salazar C; Hund TJ; Pitt GS; Mohler PJ
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12528-33. PubMed ID: 26392562
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic effect of IKr activation in a cellular model of LQT3.
Diness JG; Hansen RS; Nissen JD; Jespersen T; Grunnet M
Heart Rhythm; 2009 Jan; 6(1):100-6. PubMed ID: 19121808
[TBL] [Abstract][Full Text] [Related]
13. A distinct molecular mechanism by which phenytoin rescues a novel long QT 3 variant.
Gando I; Campana C; Tan RB; Cecchin F; Sobie EA; Coetzee WA
J Mol Cell Cardiol; 2020 Jul; 144():1-11. PubMed ID: 32339567
[TBL] [Abstract][Full Text] [Related]
14. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Potet F; Beckermann TM; Kunic JD; George AL
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
[TBL] [Abstract][Full Text] [Related]
15. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Na
Pabel S; Ahmad S; Tirilomis P; Stehle T; Mustroph J; Knierim M; Dybkova N; Bengel P; Holzamer A; Hilker M; Streckfuss-Bömeke K; Hasenfuss G; Maier LS; Sossalla S
Basic Res Cardiol; 2020 Feb; 115(2):20. PubMed ID: 32078054
[TBL] [Abstract][Full Text] [Related]
17. A Comparative Analysis of Bupivacaine and Ropivacaine Effects on Human Cardiac SCN5A Channels.
Schwoerer AP; Scheel H; Friederich P
Anesth Analg; 2015 Jun; 120(6):1226-34. PubMed ID: 25692452
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels.
Stoetzer C; Voelker M; Doll T; Heineke J; Wegner F; Leffler A
Anesth Analg; 2017 Jan; 124(1):52-60. PubMed ID: 27861438
[TBL] [Abstract][Full Text] [Related]
19. Molecular basis of the inhibition of the fast inactivation of voltage-gated sodium channel Nav1.5 by tarantula toxin Jingzhaotoxin-II.
Huang Y; Zhou X; Tang C; Zhang Y; Tao H; Chen P; Liu Z
Peptides; 2015 Jun; 68():175-82. PubMed ID: 25817910
[TBL] [Abstract][Full Text] [Related]
20. Modulation of the cardiac sodium channel Na
Matasic DS; Yoon JY; McLendon JM; Mehdi H; Schmidt MS; Greiner AM; Quinones P; Morgan GM; Boudreau RL; Irani K; Brenner C; London B
J Mol Cell Cardiol; 2020 Apr; 141():70-81. PubMed ID: 32209328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
